A
license-
qualityC
maintenanceNegative results intelligence for drug discovery: inactive compounds, failed selectivity panels, terminated clinical trials, failed CRISPR screens, antibody developability failures, and more — each result carrying full provenance (source database, DOI/PMID, license)
1
MIT